Thrombotic Thrombocytopenic Purpura during Interferon Alpha Treatment for Chronic Myelogenous Leukemia

1999 ◽  
Vol 102 (3) ◽  
pp. 160-162 ◽  
Author(s):  
L. Lacotte ◽  
A. Thierry ◽  
V. Delwail ◽  
B. Dreyfus ◽  
F. Guilhot
Keyword(s):  
Thrombotic Thrombocytopenic Purpura ◽  
Chronic Myelogenous Leukemia ◽  
Interferon Alpha ◽  
Myelogenous Leukemia ◽  
Thrombocytopenic Purpura ◽  
Interferon Alpha Treatment

Thrombotic Thrombocytopenic Purpura Complicating Chronic Myelogenous Leukemia Treated with Interferon-α

1998 ◽  
Vol 100 (4) ◽  
pp. 204-206 ◽  
Author(s):  
Rita Rachmani ◽  
Abraham Avigdor ◽  
Mona Youkla ◽  
Pia Raanani ◽  
Moshe Zilber ◽  
...  
Keyword(s):  
Thrombotic Thrombocytopenic Purpura ◽  
Chronic Myelogenous Leukemia ◽  
Myelogenous Leukemia ◽  
Interferon Α ◽  
Thrombocytopenic Purpura

Results of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older

1996 ◽  
Vol 100 (4) ◽  
pp. 452-455 ◽  
Author(s):  
Jorge Cortes ◽  
Hagop Kantarjian ◽  
Susan O'Brien ◽  
L.E. Robertson ◽  
Sherry Pierce ◽  
...  
Keyword(s):  
Chronic Myelogenous Leukemia ◽  
Interferon Alpha ◽  
Myelogenous Leukemia ◽  
Interferon Alpha Therapy ◽  
Alpha Therapy

scholarly journals Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia

Leukemia ◽  
1998 ◽  
Vol 12 (4) ◽  
pp. 455-462 ◽  
Author(s):  
J Cortes ◽  
L Fayad ◽  
H Kantarjian ◽  
S O’Brien ◽  
M-S Lee ◽  
...  
Keyword(s):  
Chronic Myelogenous Leukemia ◽  
Interferon Alpha ◽  
Myelogenous Leukemia ◽  
Hla Phenotype

scholarly journals Thrombotic Microangiopathy with Skin Localization Secondary to Cytarabine-Daunorubicin Association: Report of a Case

2012 ◽  
Vol 2012 ◽  
pp. 1-4
Author(s):  
S. Regragui ◽  
S. Amelal ◽  
S. Astati ◽  
M. Zine ◽  
N. Alami Drideb ◽  
...  
Keyword(s):  
Organ Failure ◽  
Thrombotic Thrombocytopenic Purpura ◽  
Hemolytic Anemia ◽  
Induction Chemotherapy ◽  
Thrombotic Microangiopathy ◽  
Acute Myelogenous Leukemia ◽  
Myelogenous Leukemia ◽  
Organ Transplants ◽  
Thrombocytopenic Purpura ◽  
Acute Myelogenous

The thrombotic microangiopathy is a syndrome characterized by the combination of mechanical hemolytic anemia, peripheral thrombocytopenia, and organ failure of variable severity. In addition to the idiopathic form, several cases are identified as secondary to pregnancy, infections, disease systems, organ transplants, and cancer. Other forms are secondary to drugs including antimitotics. We report the case of a patient followed for acute myelogenous leukemia. She received induction chemotherapy combining daunorubicin and cytarabine, complicated by thrombotic thrombocytopenic purpura.

Sign in / Sign up

Export Citation Format

Share Document